Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Scientific Reports|November 22, 2018
Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
Ugeskrift for Laeger|May 14, 2015
[Status and perspectives on chronic myeloproliferative neoplasm treatment]Lukas Frans Ocias, Morten Orebo Holmström, Caroline Hasselbalch Riley, et al.
Scientific Reports|July 30, 2017
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
The Lancet. Haematology|September 9, 2023
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort studyTrine Trab, Joachim Baech, Lasse Hjort Jakobsen, et al.
Annals of Medicine|March 3, 2022
Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphomaKim Oren Gradel, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
British Journal of Haematology|July 13, 2025
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based studyFreja Tang Severinsen, Mikkel Runason Simonsen, Eva Futtrup Maksten, et al.
Leukemia & Lymphoma|March 11, 2026
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphomaEmil Ramsø Kyvsgaard, Alexander Djupnes Fuglkjær, Ahmed Ludvigsen Al-Mashhadi, et al.
European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.
Leukemia Research|July 6, 2013
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alphaThomas Stauffer Larsen, Katrine F Iversen, Esben Hansen, et al.
Annals of Hematology|December 31, 2024
Validation of prognostic models in elderly patients with diffuse large B-cell lymphoma in a real-world nationwide population-based study - development of a clinical nomogramJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Scientific Reports|November 22, 2018
Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
Ugeskrift for Laeger|May 14, 2015
[Status and perspectives on chronic myeloproliferative neoplasm treatment]Lukas Frans Ocias, Morten Orebo Holmström, Caroline Hasselbalch Riley, et al.
Scientific Reports|July 30, 2017
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
The Lancet. Haematology|September 9, 2023
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort studyTrine Trab, Joachim Baech, Lasse Hjort Jakobsen, et al.
Annals of Medicine|March 3, 2022
Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphomaKim Oren Gradel, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
British Journal of Haematology|July 13, 2025
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based studyFreja Tang Severinsen, Mikkel Runason Simonsen, Eva Futtrup Maksten, et al.
Leukemia & Lymphoma|March 11, 2026
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphomaEmil Ramsø Kyvsgaard, Alexander Djupnes Fuglkjær, Ahmed Ludvigsen Al-Mashhadi, et al.
European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.
Leukemia Research|July 6, 2013
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alphaThomas Stauffer Larsen, Katrine F Iversen, Esben Hansen, et al.
Annals of Hematology|December 31, 2024
Validation of prognostic models in elderly patients with diffuse large B-cell lymphoma in a real-world nationwide population-based study - development of a clinical nomogramJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Pageof 11